Related references
Note: Only part of the references are listed.Action of Modafinil-Increased Motivation Via the Dopamine Transporter Inhibition and D1 Receptors?
Jared W. Young et al.
BIOLOGICAL PSYCHIATRY (2010)
Assessment of the rewarding effects of dimenhydrinate using the conditioned place preference paradigm in mice
Thi-Lien Nguyen et al.
NEUROSCIENCE LETTERS (2010)
Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents
Neil E. Paterson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Dopamine transporter-related effects of modafinil in rhesus monkeys
Monica L. Andersen et al.
PSYCHOPHARMACOLOGY (2010)
Use of stimulants and drugs of abuse in sport: the Italian experience
Sabina Strano Rossi et al.
ADICCIONES (2009)
Efficacy and Safety of Modafinil in the Treatment of Cancer-Related Fatigue
Maryann R. Cooper et al.
ANNALS OF PHARMACOTHERAPY (2009)
Modafinil reinstates a cocaine conditioned place preference following extinction in rats
Rick E. Bernardi et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications
Nora D. Volkow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
V. Cakic
JOURNAL OF MEDICAL ETHICS (2009)
Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil
Dorota Zolkowska et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil
Wei-Min Qu et al.
JOURNAL OF NEUROSCIENCE (2008)
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
Shahrokh Amiri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Modafinil: A review of neurochemical actions and effects on cognition
Michael J. Minzenberg et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Modafinil evokes striatal [3H]dopamine release and alters the subjective properties of stimulants
Marsha M. Dopheide et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors
T. M. Korotkova et al.
NEUROPHARMACOLOGY (2007)
Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats
Matthew R. Skelton et al.
PSYCHOPHARMACOLOGY (2006)
Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment
Sandeep Vaishnavi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Modafinil attenuates disruptions in cognitive performance during simulated night-shift work
Carl L. Hart et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration
WW Stoops et al.
PSYCHOPHARMACOLOGY (2005)
Modafinil for excessive sleepiness associated with shift-work sleep disorder
CA Czeisler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?
DC Randall et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
A prospective trial of modafinil as an adjunctive treatment of major depression
C DeBattista et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia
DC Turner et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Effects of modafinil on working memory processes in humans
U Müller et al.
PSYCHOPHARMACOLOGY (2004)
Effects of modafinil on cognitive and meta-cognitive performance
JV Baranski et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2004)
Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
MH Rosenthal et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder
DC Turner et al.
BIOLOGICAL PSYCHIATRY (2004)
Cognitive enhancing effects of modafinil in healthy volunteers
DC Turner et al.
PSYCHOPHARMACOLOGY (2003)
Study of the addictive potential of modafinil in naive and cocaine-experienced rats
V Deroche-Gamonet et al.
PSYCHOPHARMACOLOGY (2002)
Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis:: a two centre phase 2 study
KW Rammohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil
AV Nieves et al.
CLINICAL NEUROPHARMACOLOGY (2002)
Modafinil augmentation of antidepressant treatment in depression
MA Menza et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
